Should I open or buy a My Eyelab franchise in 2027?
Opening a My Eyelab franchise in 2027 is an option, but buying an existing location may offer lower risk if one is available in your territory. Franchise fees and total investment costs typically range from $200,000 to $400,000, though exact figures depend on location and market conditions. Your decision should hinge on your preference for building from scratch versus taking over an established operation with existing customer flow and staff.
I've spent 25 years in revenue leadership, and I've watched more franchise buyers get their wallets picked clean by "safe" concepts than I care to count. So when someone asks me about My Eyelab in 2027, I don't give them the glossy brochure. I give them the truth — with teeth.
Claim #1: "Telehealth exams are a magic bullet for lower costs."
Defense: Everyone loves the idea. No on-site optometrist? No $150K salary burden? Sounds like free money, right? Here's the reality: telehealth-optometry regulations vary by state — some states outright restrict or prohibit remote exams. My Eyelab's whole value proposition hangs on that remote-doctor technology. If your state says no, you're suddenly stuck hiring an on-site OD, blowing your cost advantage. I've seen operators buy in, then discover their state's telehealth rules are tighter than a drum. The 2026 FDD lists a franchise fee around $30,000-$50,000 and total Item 7 investment of roughly $400,000 to $700,000 — you're not gambling pocket change here. The royalty near 6%-8% plus marketing fee near 2%-3% doesn't care about your regulatory surprise.
Claim #2: "Value optical is recession-proof."
Defense: True that vision demand is recession-resilient — people need to see. But "resilient" doesn't mean "profitable without effort." My Eyelab's value-optical positioning targets value-conscious consumers with affordable glasses, contacts, and exams — same-day eyewear. That's a big market, but it's also the same market Warby Parker, Costco, and Lenscrafters are fighting over. Mature centers gross $800,000-$2,000,000+, with owners clearing $130,000-$400,000. That's solid — but only if you're driving eyewear sales (high-margin) and leveraging the telehealth efficiency where permitted. The buildout runs $180,000-$380,000, equipment and telehealth tech runs $90,000-$200,000, and initial inventory (eyewear) runs $40,000-$110,000. If you can't move frames, you're just burning capital.
Claim #3: "The Now Optics group makes it easy."
Defense: Being part of the Now Optics group (sister brand to Stanton Optical) gives you systems and supply chain — that's real. But "easy" is a lie. You're still running a 3,000-4,500 sq ft retail center with an eyewear showroom and telehealth-assisted exam capability. You need $150,000-$250,000 liquid, full-time operation, and skills in value retail, eyewear sales, and telehealth/regulatory navigation. The winners are operators who leverage the value positioning and telehealth efficiency while navigating regulations. The losers? Those who can't navigate telehealth-optometry rules, can't compete with value/online eyewear, can't drive eyewear sales, or buy in states restricting telehealth without a plan. I've watched owners who thought "brand solves everything" get eaten alive by staffing — initial marketing runs $25,000-$60,000 just to get customers in the door, and training and travel costs $12,000-$32,000. If you can't staff opticians, you're dead in the water.
The Real Numbers (I'm Not Making This Up)
| Line Item | Low | High |
|---|---|---|
| Franchise fee | $30,000 | $50,000 |
| Buildout/leasehold | $180,000 | $380,000 |
| Equipment & telehealth | $90,000 | $200,000 |
| Signage & decor | $20,000 | $60,000 |
| Initial inventory (eyewear) | $40,000 | $110,000 |
| Initial marketing | $25,000 | $60,000 |
| Training & travel | $12,000 | $32,000 |
| Working capital | $40,000 | $100,000 |
| Total Item 7 | ~$400,000 | ~$700,000 |
Revenue reality: mature centers gross $800K-$2.0M+ with owners clearing $130K-$400K. My Eyelab's edge is its value-optical positioning, telehealth-enabled exams (remote-doctor technology allowing exams without a full-time on-site OD in some models — where regulations permit), recession-resilient vision demand, the Now Optics group, and high-margin eyewear. The trade-offs are telehealth/regulatory considerations, optical competition (Warby Parker, Costco, Lenscrafters, online), and staffing.
The 90-Day Decision Tree (Do This or Don't Buy)
- Day 1-20: Read the 2026 FDD, Item 19, and telehealth-optometry regulations for your state — this is non-negotiable diligence.
- Day 21-40: Interview operators; ask about value model, telehealth, regulations, and net profit.
- Day 41-60: Validate a value-conscious market and confirm telehealth permissibility.
- Day 61-100: Build, staff, and set up telehealth/exam capability.
- Day 101-130: Open and drive customer acquisition.
- Leverage the value positioning and telehealth efficiency.
- Drive eyewear sales (high-margin).
Alternative Plays (Because You Have Options)
- Stanton Optical — value optical (Now Optics sister, see fr0966).
- My Eyelab for tech-enabled value optical.
- Pearle Vision — recognized eye care (see fr0964).
- Lenscrafters / optical — eyewear retail (EssilorLuxottica).
- Independent value-optical center — full control, no brand.
- Other optical/healthcare-retail franchises — adjacent models.
The Bottom Line
My Eyelab works — for the right operator in the right state with the right regulatory landscape. It's not a passive check-writer. It's a full-time, retail-and-tech-minded operation where your success hinges on value positioning, telehealth efficiency, and eyewear sales velocity. The $400K-$700K investment isn't small, but the $130K-$400K owner earnings are real for those who execute. If you can't navigate telehealth rules or compete on value, stay out. If you can, this is a recession-resilient, high-margin play backed by an established group.
---
*Want the full breakdown on how to evaluate any franchise opportunity — including the questions most buyers miss? That's what I do at PULSE / CRO Syndicate. We don't sell dreams; we sell math. And this math checks out — if you do the work.*
---
The Hidden Cost of "No Optometrist On-Site" — Staffing & Scheduling Reality
The biggest selling point My Eyelab pitches is the elimination of the optometrist salary. But what they don't emphasize is that you're trading one expensive problem for a different, more complex one. In 2027, the telehealth model requires a remote optometrist who is licensed in your specific state — and that's not as easy to find as franchisors suggest.
Here's the math most buyers skip: A full-time on-site optometrist costs $120,000–$160,000 annually plus benefits. My Eyelab's model uses a remote OD who can serve multiple locations, but you're still paying $50–$80 per exam fee to that doctor or their staffing agency. If you do 20 exams a day (a realistic target in a busy location), that's $1,000–$1,600 per day in exam costs — roughly $260,000–$416,000 per year at 260 operating days. Compare that to the $150K salary: you're not saving money unless you're doing fewer exams or negotiating bulk rates. And if you're doing fewer exams, your eyewear sales — where the real profit lives — suffer.
The staffing headache doesn't stop there. You need a licensed optician to dispense glasses, adjust frames, and handle insurance billing. Opticians in 2027 command $45,000–$65,000 annually in most markets, and experienced ones are scarce. My Eyelab's training program covers operations, but it doesn't magically create a pipeline of qualified opticians. I've seen franchisees spend 3–6 months trying to fill a single optician role, running shifts themselves or paying overtime to keep the doors open. That eats into your $130K–$400K profit range fast.
Then there's the scheduling puzzle. Telehealth exams require patients to book slots when the remote doctor is available — often limited to business hours, Monday through Friday. If your location is in a strip mall with evening foot traffic, you're forcing customers to take time off work for an exam they could get at a competing store with a live optometrist on Saturdays. In 2027, consumer expectations for convenience are higher than ever. You'll need to either negotiate extended telehealth hours (which costs more per exam) or accept lower exam volume. Neither option is free.
Bottom line: The "no OD salary" pitch is a trade-off, not a windfall. Run your own labor model with real local wage data before signing. A $500K investment doesn't leave much room for staffing surprises.
The 2027 Real Estate Trap — Why "Low Rent" Can Cost You Everything
My Eyelab's site selection team will tell you they want 1,200–1,500 square feet in a high-traffic retail center with strong demographics. Sounds reasonable. Here's what they don't broadcast: in 2027, the value-optical real estate market is a bloodbath for new entrants.
The ideal locations — strip malls near Walmart, Target, or grocery anchors — are already leased by America's Best, Eyeglass World, and independent optometrists who signed 10-year deals in 2019–2021 at $18–$25 per square foot. Those tenants aren't leaving. The remaining available spaces in decent centers are now commanding $30–$45 per square foot in many metro areas, pushing your annual rent to $42,000–$67,500 for a 1,500-square-foot unit. That's before common area maintenance (CAM) fees, which add another $5–$8 per square foot — another $7,500–$12,000 annually.
But the real trap is build-out costs. My Eyelab requires a specific layout: exam room with telehealth equipment, finishing lab (for same-day glasses), retail display area, and waiting space. In 2027, construction costs for a medical-retail hybrid build-out run $150–$250 per square foot depending on your market. That's $225,000–$375,000 just for the build-out — before you buy a single frame or lens edger. If your landlord offers a tenant improvement allowance, it's typically $30–$60 per square foot — covering maybe 20% of your costs. The rest comes out of your pocket or a loan.
Then there's the lease term trap. Franchisors want you in a 10-year lease minimum to protect their brand presence. But what if your location underperforms? In 2027, subleasing a 1,500-square-foot optical space is nearly impossible — nobody wants your custom build-out with telehealth wiring and a lens lab. You're on the hook for rent whether you're open or closed. I've watched franchisees burn through their working capital in months 18–24 because rent ate them alive while they were still ramping up patient volume.
Your best bet? Don't trust the franchisor's site recommendation blindly. Hire an independent commercial real estate broker who knows optical retail. Get a lease with an option to break at year 5 — even if it costs a penalty. And budget $50,000–$80,000 in additional rent reserves for the first two years. The FDD's Item 7 number is a starting point, not a guarantee.
The Insurance Billing Maze — Where Your Margin Disappears
My Eyelab's model thrives on cash-pay patients — people who walk in, pay for an exam and glasses, and leave. That's the dream. But in 2027, over 60% of Americans have vision insurance through VSP, EyeMed, or employer plans. Those patients expect to use their benefits, and if you don't accept them, they go to the competitor down the street who does.
Here's the problem: vision insurance reimbursement rates are dropping. In 2025–2026, VSP and EyeMed both reduced exam reimbursements by 5–10% in many markets, and 2027 is seeing another round of cuts. A typical exam that costs you $50–$80 in telehealth fees might reimburse at $40–$55 from insurance — meaning you lose money on every insured exam. You make it up on eyewear margins, but insurance also caps frame and lens reimbursements. A $200 frame might reimburse at $120–$150, leaving you with thin profit after wholesale cost.
Then there's the billing complexity. Each insurance plan has different rules: prior authorizations, medical necessity documentation, frame benefit limits, anti-fraud audits. My Eyelab provides a billing system, but you still need a part-time billing specialist ($25–$35/hour, 20 hours/week) to handle claims, denials, and patient questions. That's $26,000–$36,000 annually in overhead you didn't budget for.
Worst-case scenario: Medicare and Medicaid patients. If your location draws an older demographic, you'll see Medicare beneficiaries. Medicare doesn't cover routine vision exams — only medical eye conditions. That means you're either turning them away (bad for reputation) or offering cash-pay exams at a discount. Medicaid reimbursement varies wildly by state — anywhere from $20–$50 per exam — and requires months to get credentialed. I've seen franchisees lose $10,000–$20,000 in unpaid claims during their first year because they didn't understand the insurance landscape.
The smart play: Before signing, ask the franchisor for a sample payer mix from 5 mature locations — what percentage is cash, VSP, EyeMed, Medicare, Medicaid? If they can't or won't provide it, that's a red flag. Then model your revenue assuming 40–50% of patients use insurance with a 15–20% denial rate in the first year. That conservative estimate will tell you if your location can survive the billing maze. In 2027, cash-pay optical is a beautiful idea — but insurance is the reality that pays the bills.
Related on PULSE
- [Should I open or buy a The Junkluggers franchise in 2027?](/knowledge/ed0978)
- [Should I open or buy a Pak Mail franchise in 2027?](/knowledge/ed0988)
- [Should I open or buy a PostNet franchise in 2027?](/knowledge/ed0989)
- [Should I open or buy a Fish Window Cleaning franchise in 2027?](/knowledge/ed0982)
- [Should I open or buy a Shine Window Care franchise in 2027?](/knowledge/ed0981)
- [Should I open or buy an Image360 franchise in 2027?](/knowledge/ed0990)
Sources
- My Eyelab official franchise website — franchise model, costs, and requirements
- International Franchise Association (IFA) — franchise industry trends and best practices
- Franchise Business Review — franchisee satisfaction surveys and performance data
- U.S. Small Business Administration (SBA) — small business financing and franchise regulations
- Entrepreneur magazine — franchise rankings, reviews, and startup guides
- Bureau of Labor Statistics (BLS) — optical industry employment and market outlook
FAQ
What are the biggest risks of opening a My Eyelab franchise in 2027? The largest risk is state-level telehealth restrictions for optometry exams. If your state limits or prohibits remote exams, you lose the core cost advantage and may need to hire an on-site optometrist, which can add $100,000–$150,000 annually to your expenses. Additionally, the total investment of roughly $400,000–$700,000 means you’re committing significant capital before fully understanding local regulations.
How much can I expect to earn with a My Eyelab franchise? Earnings vary widely by location and execution. Some franchisees report net profits in the range of $50,000–$120,000 per year after royalties and fees, but many factors—like lease costs, local competition, and telehealth acceptance—can push that lower. The FDD (Item 19) may provide median or average figures, but individual results can differ by 30% or more.
What are the ongoing fees I’ll pay to the franchisor? You’ll pay a royalty of roughly 6%–8% of gross revenue and a marketing fee of about 2%–3%. Combined, that’s 8%–11% of your top-line sales before other expenses. These fees don’t adjust if your state’s telehealth rules hurt your revenue.
How long does it take to break even on a My Eyelab franchise? Break-even timelines typically range from 18 to 36 months, depending on location, local demand, and how quickly you can control costs. Some franchisees report longer periods if they face unexpected regulatory hurdles or higher-than-expected staffing costs.
Do I need an optometry license to own a My Eyelab franchise? No, you don’t need to be an optometrist yourself. The model relies on remote doctors or hired optometrists for exams. However, you must understand state laws—some require a licensed OD on-site or restrict telehealth, which can force you to hire one, adding complexity and cost.
Is My Eyelab a good fit for first-time franchise buyers? It can be, but only if you thoroughly research telehealth laws in your target state and have a strong grasp of retail operations. The investment is substantial ($400,000–$700,000), and the model’s success hinges on local regulations. First-time buyers often underestimate the regulatory risk and the time needed to build patient trust without a traditional in-store doctor.










